Rubus niveus (Mysore Raspberry)

Rubus niveus (Mysore Raspberry) is a wild-harvested berry whose root and fruit extracts contain bioactive polyphenols, including ellagitannins and anthocyanins, that demonstrate chemoprotective and antitumor activity. These compounds reduce oxidative DNA damage and inhibit tumor cell proliferation primarily through free radical scavenging and modulation of cellular stress response pathways.

Origin & History

Rubus niveus (Mysore Raspberry) is a perennial shrub in the Rosaceae family, native to India and parts of Asia, with aerial parts (leaves, stems) and roots traditionally harvested for medicinal use. The plant is processed into polyphenolic-rich extracts using organic solvents like acetone or ethanol, yielding compounds including triterpenoids, flavonoids, and phenolic acids.

Historical & Cultural Context

Rubus niveus has been used in Indian traditional medicine for treating wounds, burns, inflammation, dysentery, diarrhea, and excessive menstrual bleeding. Root extracts have been traditionally applied for skin diseases, tumors, and wounds, suggesting long-term ethnopharmacological use in South Asian healing systems.

Health Benefits

• DNA protection and chemoprotection: Mouse studies showed significant reduction in doxorubicin-induced DNA damage (p<0.05) at 500-1000 mg/kg doses (preliminary evidence)
• Antitumor activity: Root extract (250 mg/kg) prolonged lifespan by 70% in mice with Ehrlich ascites carcinoma and reduced Dalton's lymphoma tumor volume to 2.07 cm³ (preliminary evidence)
• Wound healing support: Complete epithelialization observed in mice by days 13-17 with root extract treatment (preliminary evidence)
• Antioxidant effects: Polyphenolic compounds including quercetin provide free radical scavenging activity (preliminary evidence)
• Anti-inflammatory potential: Traditional use for inflammation supported by polyphenol content, though no clinical studies exist (traditional evidence only)

How It Works

Rubus niveus polyphenols — particularly ellagitannins and anthocyanins — scavenge reactive oxygen species (ROS) and reduce oxidative adduct formation on DNA, thereby limiting strand breaks induced by genotoxic agents such as doxorubicin. The root extract appears to modulate tumor microenvironment dynamics by reducing ascitic fluid volume and tumor cell viability, possibly through inhibition of topoisomerase II and suppression of NF-κB-mediated pro-survival signaling. Anthocyanins may additionally upregulate Nrf2-ARE antioxidant response elements, enhancing endogenous glutathione production.

Scientific Research

No human clinical trials, RCTs, or meta-analyses on Rubus niveus were identified. Available evidence consists entirely of preclinical mouse studies, including genotoxicity/chemoprotection research (PMID: 25681544) showing DNA protective effects at 500-1000 mg/kg, and antitumor/wound healing studies (PMID: 24941297) demonstrating 70% lifespan extension in cancer models.

Clinical Summary

Available evidence for Rubus niveus is limited exclusively to in vitro cell studies and in vivo mouse models; no human clinical trials have been conducted to date. In a murine Ehrlich ascites carcinoma model, oral administration of root extract at 250 mg/kg significantly prolonged lifespan by approximately 70% and reduced tumor volume compared to untreated controls. Separately, doses of 500–1000 mg/kg of fruit or root extract demonstrated statistically significant reductions in doxorubicin-induced DNA damage (p<0.05) as measured by comet assay in mouse leukocytes. These findings are preliminary and cannot be extrapolated to human therapeutic dosing without controlled clinical investigation.

Nutritional Profile

Rubus niveus (Mysore Raspberry) fruit and plant parts contain the following characterized components: Macronutrients — fruit is predominantly water (~85-88%), with modest carbohydrate content (~8-10g/100g fresh weight), minimal protein (~1-1.5g/100g), and low fat (<0.5g/100g), consistent with other Rubus species. Dietary fiber estimated at 3-5g/100g (pectin and cellulose fractions). Bioactive compounds (primary documented constituents): Polyphenols — ellagic acid and ellagitannins are primary documented phytochemicals identified in root and leaf extracts, consistent with genus-wide patterns; anthocyanins (cyanidin-3-glucoside, cyanidin-3-rutinoside) contribute to characteristic dark purple-black fruit pigmentation, estimated 50-150mg/100g fresh fruit based on comparable Rubus species. Flavonoids — quercetin and kaempferol glycosides detected in leaf extracts. Alkaloids — trace alkaloids reported in root extracts. Tannins — condensed tannins (proanthocyanidins) present in bark and root, contributing to astringency; exact concentrations not formally published. Terpenoids — ursolic acid and oleanolic acid identified in root extracts, likely contributors to observed antitumor activity in mouse models. Vitamins: Vitamin C estimated 15-25mg/100g (fresh fruit, unverified analytically for this species); B-vitamins presumed present at trace levels consistent with Rubus genus. Minerals: Potassium, calcium, and magnesium expected as dominant minerals (~100-200mg, ~20-40mg, ~15-25mg per 100g respectively), based on genus data; no species-specific mineral analysis published. Bioavailability notes: Ellagitannins require gut microbiome conversion to urolithins for systemic activity; polyphenol bioavailability likely moderate (~5-20%) and influenced by food matrix and individual microbiome composition. Root extract phytochemicals used in experimental studies are ethanol/aqueous extracts at 250-1000mg/kg doses in mice, and direct human bioavailability data is not yet established.

Preparation & Dosage

No clinically studied human dosages exist. Preclinical mouse studies used 500-2000 mg/kg body weight of aerial parts extract (with caution above 1000 mg/kg due to potential genotoxic effects at 2000 mg/kg) and 250 mg/kg of acetone root extract for antitumor effects. Human equivalent doses have not been established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Quercetin, Green Tea Extract, Turmeric, Resveratrol, Milk Thistle

Safety & Interactions

No formal human safety or toxicology studies have been published for Rubus niveus extracts, making definitive risk profiling impossible at this time. Because the plant contains ellagitannins that are metabolized to urolithins by gut microbiota, individuals with dysbiosis or inflammatory bowel conditions may experience variable absorption and gastrointestinal tolerance. Theoretical interactions exist with cytotoxic chemotherapy agents such as doxorubicin, as the extract's antioxidant activity could potentially reduce drug-induced oxidative stress — which is part of doxorubicin's mechanism — though this has not been clinically evaluated. Pregnant or breastfeeding individuals should avoid supplemental extracts due to the complete absence of safety data in these populations.